GlassScriptPhysician profile
Samer Mowakeaa
NPI 1821223520
$5,587.12
in general payments reported to CMS, 2019-2025
15 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,796 · 2020: $341 · 2021: $215 · 2022: $98.51 · 2023: $482 · 2024: $463 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,596.99 | 2019 | |
| Penumbra, INC. | $1,016.88 | 2019 | |
| Abiomed | $435.62 | 2019-2024 | Impella |
| Medtronic, INC. | $320.96 | 2021-2024 | Onyx Frontier, Hawkone |
| Abbott Laboratories | $282.20 | 2020-2025 | Coroflow, Thoratec Heartmate 3 Lvas Implant Kit |
| Inari Medical, INC. | $268.26 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $154.86 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $132.80 | 2024-2025 | Sapien 3 Ultra Resilia, Hemosphere, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.68 | 2019-2022 | |
| Becton, Dickinson and Company | $85.74 | 2025 | Hemosphere |
| Stryker Corporation | $63.92 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Terumo Medical Corporation | $46.63 | 2023 | Angio-Seal, Azur Cx Detachable, R2p Misago |
| Janssen Pharmaceuticals, INC | $38.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $24.85 | 2024 | |
| Biosense Webster, INC. | $15.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samer Mowakeaa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.